Omeros Corporation (NASDAQ: OMER) is working its way to the top in the pre-market hours this morning after reporting its earnings for the fourth quarter and full 2018 year. Of course, the earnings were positive, exciting investors and pushing the stock up. Today, we’ll talk about: The financial results; what we’re seeing from OMER stock … Read more
Omeros Corporation (NASDAQ: OMER) is tumbling in the market this morning after the company announced the pricing of an offering. Unfortunately, the pricing showed that the transaction will lead to heavy dilution at a very steep discount. Of course, that news upset investors and sent the stock falling. Today, we’ll talk about: The offering; what … Read more
Omeros Corporation (NASDAQ: OMER) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that it has received Orphan Medicinal Products designation from the European Commission. Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about: The … Read more
Omeros Corporation (NASDAQ: OMER) is having a great start to the trading session early on this morning, and for good reason. The company has received a nod toward orphan drug designation in Europe with regard to a lead candidate in the it’s pipeline. Today, we’ll talk about: The orphan drug designation news; what we’re seeing … Read more
Omeros Corporation (NASDAQ: OMER) is having an overwhelmingly strong day in the market today, and for good reason. The company reported its financial results for the first quarter, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: What we saw from earnings; what we’re seeing from the stock; and what … Read more
Omeros Corporation (NASDAQ: OMER) is having an overwhelmingly strong start to the trading session this morning. However, if you do some digging on Yahoo! Finance or the investor relations website for the company, you’ll see that no news was released that is company specific. Nonetheless, there’s a good reason for the gains today, as American congressional … Read more
Omeros Corporation (NASDAQ: OMER) is having an overwhelmingly strong day in the market today, and for good reason. The company announced data from a key clinical trial, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the data, what we’re seeing from the stock, and what we’ll be … Read more
Omeros Corporation (NASDAQ: OMER) is having a pretty strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced FDA news that seems to be a source of excitement among investors. Today, we’ll talk about the news, what we’re seeing from the stock, and what we’ll be … Read more
Omeros Corporation (NASDAQ: OMER) is having an incredibly strong day in today’s trading session and for good reason. The company was just granted breakthrough therapy designation with regard to a key treatment candidate. As a result, investor excitement ensued, leading to gains in the stock and prompting our partners at Trade Ideas to alert us … Read more
Omeros Corporation (NASDAQ: OMER) Omeros Corporation is having a great start to the trading session today after reporting strong Phase 2 clinical data. With the strong data in mind, investors pushed the stock toward the top, and as is almost always the case, our partners at Trade Ideas were the first to alert us of … Read more